Trigeminal Neuralgia
A nerve disorder causing sudden, severe, electric shock-like pain in the face, often triggered by simple actions like brushing teeth or chewing.
Emergency Management: Trigeminal Neuralgia Crisis: A state of continuous, severe paroxysms rendering the patient unable to speak, eat, or drink. Requires hospitalization for IV hydration and IV anticonvulsant loading (e.g., Fosphenytoin or IV Lidocaine infusion) to break the pain cycle.
Trigeminal neuralgia (TN) is a severe, chronic neuropathic pain disorder affecting the trigeminal nerve (Cranial Nerve V). It is characterized by sudden, unilateral, brief, stabbing, or electric shock-like facial pain in the distribution of one or more branches of the trigeminal nerve.
Detailed Overview
Considered one of the most painful conditions known to medicine, TN drastically impacts quality of life, often leading to severe weight loss (due to pain when eating) and profound depression or suicidality. The pain occurs in paroxysms lasting from a fraction of a second to two minutes. It is almost always strictly unilateral. The attacks are typically triggered by innocuous mechanical stimuli to the face, such as washing, shaving, chewing, or even a light breeze.
Epidemiology & Demographics
Incidence is roughly 4-5 per 100,000 population per year. It is more common in women (ratio 1.5:1) and predominantly affects individuals over the age of 50. If presenting in a young patient (e.g., 20s-30s), it highly suggests an underlying demyelinating disease like Multiple Sclerosis.
Etiological Mechanism
The majority of classical TN cases (80-90%) are caused by vascular compression of the trigeminal nerve root entry zone by an aberrant loop of an artery or vein. Secondary TN can be caused by Multiple Sclerosis (demyelinating plaques), cerebellopontine angle tumors (vestibular schwannoma, meningioma), or arteriovenous malformations.
Primary Causes
Classical: Neurovascular compression, most commonly by the Superior Cerebellar Artery (SCA) compressing the nerve root. Secondary: Multiple Sclerosis, tumors, or physical trauma/dental procedures.
Chronic mechanical compression by a blood vessel at the trigeminal nerve root entry zone (near the pons) causes localized focal demyelination. This demyelination disrupts the insulating myelin sheath, allowing ephaptic transmission ('short-circuiting') between adjacent nerve fibers. Touch/vibration signals traveling via heavily myelinated A-beta fibers jump to unmyelinated pain fibers (A-delta and C fibers). Furthermore, the damaged nerve becomes hyper-excitable, leading to spontaneous generation of ectopic action potentials. The brain interprets these intense, spontaneous volleys as severe facial pain.
Diagnostic Criteria & Guidelines
Clinical diagnosis based on the International Classification of Headache Disorders (ICHD-3). Criteria: 1) Recurrent paroxysms of unilateral facial pain in trigeminal distribution. 2) Pain is lasting fraction of a second to 2 minutes, severe intensity, electric shock-like. 3) Precipitated by innocuous stimuli to affected side. 4) No other neurological deficit. Brain MRI is required in all patients to rule out secondary causes.
Pharmacological therapy is the mainstay. Anticonvulsants are first-line. Carbamazepine is the gold standard (start 100 mg PO BID, titrate up to 1200 mg/day based on efficacy and tolerance). Oxcarbazepine (start 300 mg PO BID, titrate up to 1800 mg/day) is equally effective with slightly better tolerability.
Second-Line & Adjunctive Therapy
If first-line fails or side effects (dizziness, ataxia) are intolerable, use Baclofen, Gabapentin, Pregabalin, or Lamotrigine as add-on therapy or monotherapy. If medical therapy fails entirely, surgical intervention is indicated.
Surgical & Procedural Management
Microvascular Decompression (MVD) is the most definitive and durable surgery. A craniotomy is performed, and a Teflon sponge is placed between the offending artery and the trigeminal nerve. Alternative ablative procedures (for older/frail patients) include Gamma Knife Radiosurgery, percutaneous glycerol rhizotomy, or radiofrequency thermocoagulation.
Patient Counseling & Advice
Warn patients on Carbamazepine/Oxcarbazepine about the risk of drowsiness, dizziness, and the rare but serious risk of Stevens-Johnson syndrome (especially in Asian patients with HLA-B*1502). Emphasize the importance of regular blood tests to monitor sodium levels (hyponatremia risk) and liver function.
Follow-Up & Monitoring Schedule
Frequent follow-up initially to titrate medications to effective pain control. Monitor basic metabolic panel (specifically serum sodium for Oxcarbazepine-induced SIADH), complete blood count (agranulocytosis risk with Carbamazepine), and liver function tests every 3-6 months.
Preventive Strategies
No known lifestyle modifications can prevent the onset of trigeminal neuralgia.
Variable. Medical therapy is initially effective in up to 80% of patients, but tolerance or severe side effects often develop over years. Microvascular decompression provides long-term pain relief (cure) in 70-80% of cases, though recurrence is possible.